TRIMPEX 200 Drug Patent Profile
Which patents cover Trimpex 200, and what generic alternatives are available?
Trimpex 200 is a drug marketed by Roche and is included in one NDA.
The generic ingredient in TRIMPEX 200 is trimethoprim. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the trimethoprim profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trimpex 200
A generic version of TRIMPEX 200 was approved as trimethoprim by DR REDDYS LABS SA on July 30th, 1982.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRIMPEX 200?
- What are the global sales for TRIMPEX 200?
- What is Average Wholesale Price for TRIMPEX 200?
Summary for TRIMPEX 200
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 138 |
| Patent Applications: | 4,917 |
| DailyMed Link: | TRIMPEX 200 at DailyMed |
US Patents and Regulatory Information for TRIMPEX 200
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | TRIMPEX 200 | trimethoprim | TABLET;ORAL | 017952-002 | Nov 9, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
